ArticleGland surgery2026
Construction of a predictive model for postoperative pancreatic fistula following pancreaticoduodenectomy and an exploration of inflammatory biomarker associations.
Article in Gland surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Clinically relevant postoperative pancreatic fistula (CR-POPF) remains a significant cause of morbidity after pancreaticoduodenectomy (PD). Existing predictive tools, such as the Fistula risk score (FRS), demonstrate inconsistent performance. This study aimed to develop a nomogram with superior predictive accuracy for CR-POPF. Methods: This retrospective cohort study analysed 1,026 PD patients (70% training, 30% validation). Least absolute shrinkage and selection operator (LASSO) and multivariate logistic regression were used to identify independent predictors and construct a dynamic nomogram. Model performance was assessed via the area under the curve (AUC), calibration, and decision curve analysis (DCA). Results: CR-POPF occurred in 18.4% of the cohort. Multivariable analysis identified five independent predictors: soft pancreatic texture, small pancreatic duct diameter, elevated body mass index (BMI), prolonged operation time, and absence of diabetes mellitus. Inflammatory markers were not retained in the final model. The nomogram showed robust discrimination with AUCs of 0.770 (training) and 0.759 (validation), significantly outperforming both the alternative FRS (a-FRS) (AUC =0.579) and the traditional FRS (AUC =0.529). Conclusions: We successfully developed and internally validated a superior nomogram integrating anatomical, metabolic, and procedural factors. This highly accurate tool facilitates precise preoperative and intraoperative risk stratification, guiding tailored preventive strategies to mitigate the burden of POPF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.